Eli Lilly and Company

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 501 20
 
 
C07D HETEROCYCLIC COMPOUNDS 318 16
 
 
C07K PEPTIDES 102 34
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 62 34
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 52 84
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 47 104
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 40 88
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 35 33
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 35 62
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 29 61
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0232,483 BACE INHIBITORS Oct 17, 13 Aug 20, 15 [C07D]
2015/0218,107 AGGRECANASE INHIBITORS Oct 18, 13 Aug 06, 15 [C07D, A61K]
2015/0203,471 METHODS FOR IMPROVING CHICKEN PRODUCTION Sep 24, 13 Jul 23, 15 [C07D, C07C, A23K]
2015/0183,877 Multi-Specific IgG-(Fab)2 Constructs Containing T-Cell Receptor Constant Domains Jul 15, 13 Jul 02, 15 [C07K]
2015/0175,708 Multifunctional Antibodies Binding to EGFR and MET Dec 17, 14 Jun 25, 15 [C07K]
2015/0166,535 NOVELTRIAZOLO-PYRIDINE COMPOUND Dec 04, 14 Jun 18, 15 [C07D]
2015/0150,665 TRANSDERMAL DISPENSING APPARATUS AND METHODS Feb 10, 15 Jun 04, 15 [A61D]
2015/0152,158 METHODS TO RESTORE GLYCEMIC CONTROL Feb 10, 15 Jun 04, 15 [C07K]
2015/0141,327 FIBROBLAST GROWTH FACTOR 21 VARIANTS Jun 05, 13 May 21, 15 [C07K]
2015/0141,335 THERAPEUTIC USES OF FIBROBLAST GROWTH FACTOR 21 PROTEINS May 09, 13 May 21, 15 [A61K]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,073,856 Phenyl methanesulfonamide derivatives useful as MGAT-2 inhibitors Jan 16, 13 Jul 07, 15 [C07D, A61K]
9,073,901 DGAT2 inhibitors Nov 19, 14 Jul 07, 15 [A01N, C07D, A61K]
9,073,991 CGRP antibodies Jun 07, 11 Jul 07, 15 [C12P, A61K, C07K]
9,067,920 Compounds useful for inhibiting Chk1 Nov 01, 11 Jun 30, 15 [C07D, C07C, A61K]
9,062,050 Inhibitor of JAK1 and JAK2 Jun 05, 13 Jun 23, 15 [C07D, A61K]
9,056,844 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists Nov 15, 11 Jun 16, 15 [C07D, C07C, A61K]
D732162 Automatic injection device Mar 14, 13 Jun 16, 15 [2402]
9,050,371 PEGylated insulin lispro compounds Jun 09, 09 Jun 09, 15 [A61K, C07K]
9,044,487 Hematopoietic neoplasm chemotherapy Apr 30, 14 Jun 02, 15 [A61K]
9,044,553 Apparatus for injecting a pharmaceutical with automatic syringe retraction following injection Mar 08, 10 Jun 02, 15 [A61M]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0275,049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS ABAN Oct 19, 12 Sep 18, 14 [C07D, A61K]
2014/0206,613 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Mar 31, 14 Jul 24, 14 [C07K]
2014/0050,763 MODIFIED VIRAL PARTICLES WITH IMMUNOGENIC PROPERTIES AND REDUCED LIPID CONTENT USEFUL FOR TREATING AND PREVENTING INFECTIOUS DISEASES ABAN Oct 30, 13 Feb 20, 14 [A61K]
2013/0228,136 LIQUID DISPENSER ABAN Apr 17, 13 Sep 05, 13 [A01K]
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Sep 14, 12 Jan 24, 13 [A61P, A61K]
2012/0323,001 BACE INHIBITORS ABAN Aug 16, 12 Dec 20, 12 [C07D]
2012/0302,547 NOVEL MCH RECEPTOR ANTAGONISTS ABAN Aug 08, 12 Nov 29, 12 [C07D, A61P, A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA ABAN Oct 28, 10 Nov 22, 12 [A61P, A61K]
2012/0231,022 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT ABAN May 27, 10 Sep 13, 12 [A61P, A61K]
2012/0195,904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES ABAN Apr 11, 12 Aug 02, 12 [A61P, A61K]
2012/0172,422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid ABAN Mar 13, 12 Jul 05, 12 [A61P, A61K]
2012/0071,490 P70 S6 KINASE INHIBITORS ABAN Nov 30, 11 Mar 22, 12 [C07D, A61P, A61K]
2012/0041,065 LAURIC ACID DISTILLATE FOR ANIMAL FEED ABAN Jul 29, 11 Feb 16, 12 [A61K]
2012/0022,140 Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel ABAN Sep 28, 11 Jan 26, 12 [A61P, A61K]
2011/0294,792 PURINE DERIVATIVES AS KINASE INHIBITORS ABAN Aug 09, 11 Dec 01, 11 [C07D, A61P, A61K]
2011/0287,019 THERAPEUTIC TARGETING OF ESCORT PROTEINS ABAN Jun 13, 11 Nov 24, 11 [A61P, A61K, C07K]
2011/0288,032 ENZASTAURIN FOR THE TREATMENT OF CANCER ABAN Dec 07, 09 Nov 24, 11 [A61P, A61K]
2011/0212,092 GLUCAGON RECEPTOR ANTAGONISTS ABAN May 16, 11 Sep 01, 11 [A61P, A61K, C07K]
2011/0212,977 P70 S6 KINASE INHIBITOR AND MTOR INHIBITOR COMBINATION THERAPY ABAN Nov 04, 09 Sep 01, 11 [A61P, A61K]
2011/0207,670 COMPOSITIONS AND METHODS OF USE FOR SOLUBLE THROMBOMODULIN VARIANTS ABAN Oct 21, 09 Aug 25, 11 [A61P, A61K, C07K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
Eli Lilly and Company
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL